Scarica l'app Stockscreener
1.71
1.16%
-0.02
Dopo l'orario di chiusura:
1.75
0.04
+2.34%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRBU Giù?
Forum
Previsione
Precedente Chiudi:
$1.73
Aprire:
$1.7
Volume 24 ore:
593.95K
Relative Volume:
0.39
Capitalizzazione di mercato:
$159.04M
Reddito:
$34.48M
Utile/perdita netta:
$-102.07M
Rapporto P/E:
-1.1712
EPS:
-1.46
Flusso di cassa netto:
$-104.90M
1 W Prestazione:
-18.57%
1M Prestazione:
+4.91%
6M Prestazione:
+35.71%
1 anno Prestazione:
-11.86%
Intervallo 1D:
$1.68
$1.77
Intervallo di 1 settimana:
$1.68
$2.11
Portata 52W:
$0.66
$2.9995
Caribou Biosciences Inc Stock (CRBU) Company Profile
Nome
Caribou Biosciences Inc
Settore
Industria
Telefono
510-982-6030
Indirizzo
2929 7TH STREET, SUITE 105, BERKELEY
Confronta CRBU con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
1.71 | 160.90M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.46 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.00 | 57.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.94 | 59.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
638.90 | 40.50B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
289.75 | 34.26B | 3.81B | -644.79M | -669.77M | -6.24 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-11-08 | Iniziato | Cantor Fitzgerald | Neutral |
| 2023-10-31 | Iniziato | Evercore ISI | Outperform |
| 2023-07-11 | Iniziato | Truist | Buy |
| 2022-02-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-12-01 | Iniziato | Oppenheimer | Outperform |
| 2021-11-30 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-15 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-08-17 | Iniziato | BofA Securities | Buy |
| 2021-08-17 | Iniziato | Citigroup | Neutral |
| 2021-08-17 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Caribou Biosciences Inc Borsa (CRBU) Ultime notizie
Is Caribou Biosciences Inc. Forming a Consolidation BaseTrade Setups With Clear Risk Limits Highlighted - beatles.ru
Caribou Biosciences CRBU Q2 2025 Earnings Preview Downside Risk Amid Clinical Trial Delays - AInvest
Sentiment Tools Show Shift in Trader Mood on Caribou Biosciences Inc.Exit Ready Momentum Stock Watchlist Expanded - beatles.ru
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 24, 2025 in Caribou Biosciences, Inc. Lawsuit – CRBU - ACCESS Newswire
Caribou Biosciences Inc. Price Targets Raised After ReboundWeekly Hot Picks With Buy Confidence Released - metal.it
What analysts say about Caribou Biosciences Inc. stockInvest confidently with professional advice - Jammu Links News
Caribou Biosciences Inc. Stock Analysis and ForecastTremendous growth potential - Jammu Links News
What makes Caribou Biosciences Inc. stock price move sharplyMaximize your returns with smart trade entries - Jammu Links News
Is Caribou Biosciences Inc. stock overvalued or undervaluedBuild wealth with steady, reliable stocks - Jammu Links News
What are the latest earnings results for Caribou Biosciences Inc.Achieve consistent double-digit growth rates - Jammu Links News
How does Caribou Biosciences Inc. compare to its industry peersBuild wealth steadily with expert advice - Jammu Links News
Is it the right time to buy Caribou Biosciences Inc. stockAchieve breakthrough investment performance - Jammu Links News
How strong is Caribou Biosciences Inc. company’s balance sheetInvest in high-yield stocks with confidence - Jammu Links News
Caribou Biosciences Inc. stock prediction for this weekPortfolio Diversification Stock Ideas From Experts - metal.it
How Interest Rate Changes Impact Caribou Biosciences Inc. Stock PerformanceLong Hold Safe Return Strategy Reviewed - metal.it
Why Caribou Biosciences Inc. stock attracts strong analyst attentionTechnical Entry Strategy for Beginners Explained - beatles.ru
How many analysts rate Caribou Biosciences Inc. as a “Buy”Earnings Report Entry Points For Fast Growth - Jammu Links News
Why is Caribou Biosciences Inc. stock attracting strong analyst attentionHigh-velocity gains - Jammu Links News
What institutional investors are buying Caribou Biosciences Inc. stockMaximize returns with strategic trading plans - Jammu Links News
What is Caribou Biosciences Inc. company’s growth strategyCapitalize on fast-growing investment opportunities - jammulinksnews.com
Published on: 2025-07-28 05:44:44 - Jammu Links News
CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
What risks could impact Caribou Biosciences Inc. stock performanceExtraordinary profit generation - Jammu Links News
What drives Caribou Biosciences Inc. stock priceFree High-Return Strategy Alerts - Autocar Professional
Following a 1.3% Decline Over Last Year, Recent Gains May Please Caribou Biosciences, Inc. (NASDAQ:CRBU) Institutional Owners - 富途牛牛
Is Caribou Biosciences Inc. a good long term investmentDynamic profit opportunities - Autocar Professional
Caribou Biosciences Inc Azioni (CRBU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.02%
3.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):